TWiV 1016: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses surveillance to track progress toward poliomyelitis eradication, genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3, evaluation of Oseltamivir used to prevent hospitalization in outpatients with Influenza, viral emissions into the air and environment after SARS-CoV-2 human challenge, has COVID-19 threatened routine childhood vaccination, successful treatment of persistent symptomatic COVID-19 infection with extended duration Nirmatrelvir/Ritonavir, anemia as a risk factor for disease progression in patients admitted for COVID-19, impact of...
Source: This Week in Virology - MP3 Edition - June 17, 2023 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Oseltamivir Redux with Ehud Sarlin, MD
Drs. Stanton and Sarlin agree that Tamiflu just isn’t worth it for most patients. Listen in as they talk about whether it makes sense to get the vaccine once you get the flu, what to tell patients about avoiding the flu in the first place, and how oseltamivir was resurrected from the dead. (Source: Everyday Medicine for Physicians)
Source: Everyday Medicine for Physicians - January 29, 2019 Category: Emergency Medicine Authors: Emergency Medicine News Emergency Medicine News Source Type: podcasts
Should You Give Patients Tamiflu?
The Centers for Disease Control and Prevention recommend oseltamivir for flu patients, and Dr. Stanton looks at what the evidence has to say. (Source: Everyday Medicine for Physicians)
Source: Everyday Medicine for Physicians - January 21, 2019 Category: Emergency Medicine Authors: Emergency Medicine News Emergency Medicine News Source Type: podcasts
TWiV 282: Tamiflu and tenure too
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler
The TWiV team reviews a meta-analysis of clinical trial reports on using Tamiflu for influenza, and suggestions on how to rescue US biomedical research from its systemic flaws.
Links for this episode
World Malaria Day
Review of oseltamivir clinical trials (Brit Med J)
Effectiveness of Tamiflu questioned (NHS choices)
Tamiflu campaign (Brit Med J)
Rescuing US biomedical research (PNAS)
Letters read on TWiV 282
Weekly Science Picks
Alan - Northampton AirportVincent - Particle...
Source: This Week in Virology - MP3 Edition - April 27, 2014 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Tamiflu US Press Conference
Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu ’s effectiveness have been overestimated, and that harms have been underreported.
Here is the audio... (Source: The BMJ Podcast)
Source: The BMJ Podcast - April 9, 2014 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Tamiflu US Press Conference
Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu’s effectiveness have been overestimated, and that harms have been underreported.
Here is the audio of a recent press conference where researchers and the BMJ's editors describe the findings of that research, and the systematic regulatory failures those findings expose.
Taking part were:
Fiona Godlee - BMJ editor in chief
Carl Heneghan - Director of Oxford University's Centre...
Source: The BMJ Podcast - April 9, 2014 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Antidepressants and tamiflu
Simon Hatcher, associate professor of psychiatry at the University of Aukland, sets out the use of newer antidepressants for the treatment of depression in adults. Deborah Cohen, BMJ's investigations editor, updates us on the Tamiflu saga, and how Roche is still holding onto its full patient data. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Fishy data
Rajiv Chowdury, a research associate from the Department of Public Health and Primary Care at the University of Cambridge, explains why eating whole fish is better than fish oil - at least when it comes to cerebrovascular disease. Also this week Peter Doshi and Tom Jefferson from the Cochrane Collaboration talk about the BMJ's open data campaign, and how publishing correspondence with Roche, the WHO and Centers for Disease Control and Prevention might reveal the missing data on Tamiflu. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
